JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

J Thorac Cardiovasc Surg 2007;133:933
© 2007 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology

Discussion

The first 20% of the full text of this article appears below.

Dr Frank W. Sellke (Boston, MA). Joe, This is a very nice extension of what was presented at the American Heart Association last year. It suggests that cyclin A2 may increase myocardial regeneration and may have some therapeutic effect in treatment of patients with chronic heart failure. I do have a couple of questions. How did the cyclin A2 affect other cell cycle proteins and factors regulating myocardial regeneration and function? You may have . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.